A Randomized, Double Masked, Controlled Study of the Efficacy, Safety, and Tolerability of Repeated Intravitreal Administration of Ranibizumab versus Bevacizumab in Subjects with Macular Edema Secondary to Branch Retinal Vein Occlusion (BRANVO) - BRANVO

Trial Profile

A Randomized, Double Masked, Controlled Study of the Efficacy, Safety, and Tolerability of Repeated Intravitreal Administration of Ranibizumab versus Bevacizumab in Subjects with Macular Edema Secondary to Branch Retinal Vein Occlusion (BRANVO) - BRANVO

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 02 Sep 2016

At a glance

  • Drugs Ranibizumab (Primary) ; Bevacizumab
  • Indications Retinal oedema
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Sep 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top